DOCSLIB.ORG

The Global Investment Banking Advisor for Asia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

The global investment banking advisor for Asia The global investment banking advisor for Asia September 2021 Experts in Asian M&A The global investment banking advisor for Asia 2021 marks 25 years of providing high-quality M&A advice Where we are Key facts We deliver global coverage for our clients from BDA’s own platform #1 Cross-border Asian sellside M&A advisor London 1996 Founded and led since then by the same team New York Seoul Shanghai Tokyo Bankers across three continents Hong Kong 100 Mumbai Ho Chi Minh City Singapore 9 Offices globally 2 Strategic partners Our services How we are organized We provide M&A advisory services for: Divestitures Acquisitions Capital raisings Chemicals Consumer Healthcare & Retail Debt advisory & restructuring transactions Valuations Industrials Services Technology 1 On the ground, with local relationships BDA Partners is #1 for Asian cross-border private sellside M&A No other firm has built the same scale, focus, connectivity and deal flow in Asia Private, cross-border Asian sellside transactions up to US$1bn EV of last five years (2016–2020) Highlights Rank Advisor # of Deals 80% of transactions involved either the sale/acquisition of an Asian asset, an Asian buyer or an Asian seller 1 34 80% of M&A transactions with BDA as sellside advisor 2 32 75% of M&A transactions were cross-border 3 31 60% of sale to a strategic buyer vs 40% of sale to financial sponsors 4 27 Long-established Asian presence 5 26 Coverage across Asia 60+ bankers in Asia 6 25 7 countries Seoul 2002 Tokyo 25 years of relationship- Shanghai 2002 1998 7 24 building Hong Kong 2000 8 22 Mumbai 2005 Ho Chi Minh City 2014 9 21 Singapore We reach Asian buyers 1996 10 19 120+ assets sold to Asian buyers 20,000+ calls made to Asian buyers 600+ transactions with Asian participation Note: (1) Target headquartered in China, India, Japan, Korea or Southeast Asia; Control transactions: i.e. a majority stake sold or acquired | Sources: Dealogic 2 Worldwide reach in the middle market A recognized global M&A platform Cross-border excellence Experts in cross-border M&A Regularly honored as a top investment banking advisor 2020 Investment Banking Firm of the Year Divested 100% stake to Divested 100% stake to Agreed to be acquired by Cross-Border Deal of the Year 2019 Cross-border Investment Bank of the Year 2021 2021 2021 Corporate Deal of the Year Investment Banking Firm of the Year 2018 Divested China phenolic resins Divested Compart Systems to Divested majority stake to Divestiture Deal of the Year (>US$100m) plant to Telecommunications Services Deal of the Year Cross-Border Deal of the Year (US$10m-US$25m) 2021 2020 2020 Cross-Border Boutique M&A Investment Banker Firm Award 2017 Investment Bank of the Year Acquired 100% of EMC Divested Thinh Phat Cables and Divested Asian electronic Holdings from Dong Viet to cleaning chemicals business to Investment Bank of the Year Transaction of the Year (£100m-£500m) Consumer Discretionary Deal of the Year for the sale of AnaJet to 2020 2020 2020 Ricoh 3 One team,globally A global senior team, interacting seamlessly with our clients and each other As an M&A-focused boutique, senior bankers globally work as one team Regional senior bankers speaking with local buyers and targets North America Europe India Korea Euan Rellie Alex Ditchfield Charlie Maynard Jonathan Aiken Sanjay Singh Kumar Mahtani Manoj Balwani Howard Lee Victor Chang Managing Partner Director Non-Executive Chairman Managing Director Managing Director Managing Director Managing Director Partner Managing Director Southeast Asia Andrew Huntley Paul DiGiacomo Simon Kavanagh Mark Webster Lars Freitag Huong Trinh Rica Wirianata Anindita Das Jakub Widzyk Managing Partner Managing Partner Partner Partner Managing Director Managing Director Managing Director Director Director (Asia/Europe) Greater China Anthony Siu Jeffrey Wang Karen Cheung Vivian Ren Dorothy Cai Lilian Gu Jason Song Partner Partner Managing Director Managing Director Director Director Director Japan Jeff Acton Hideyuki Tozawa Koichiro Yasuda Shinya Kimura Toshiaki Yokohara Partner Managing Director Chairman Director Director 4 Extensive sector expertise We are committed to six sectors Delivering valuable, real-time transactional insights to clients Our global teams are organized around six dedicated sectors, building knowledge and sharing perspectives across global markets, supported by continuous deal flow in each sector We maintain an extensive network of senior-level relationships with financial sponsors, publicly listed corporates and private companies within our sectors to deliver valuable, real-time transactional insights to our clients Deep industry knowledge Chemicals Consumer & Retail Health Industrials Services Technology Digital media Coatings Apparel & Biotech Aftermarket Business services and outsourcing Information Electronic accessories Medical tech Auto components Facility Software Materials Cosmetics Pharma Building materials management Systems Petrochemicals Food & beverage Services Electronics Recycling & waste integrators & BPO Plastics Food chains Flow control management (Business Process Specialty & fine Food services Outsourcing) Machinery chemicals Testing, inspection Jewelry Packaging & certification Luxury goods Printing Transportation & logistics 5 Our experience is a competitive advantage Expertise on the sellside We are among the most active sellside advisors in Asia. We draw on that experience to drive sellside processes that maximize value and certainty Processes that clear the market globally Positioning for value maximization Thoughtfully designed and well-run processes Global buyer outreach Positioning businesses for sale and spike valuation Tailored, creative and thoughtfully constructed Senior bankers drive buyer identification outreach processes Positioning led by senior sector bankers from Our reach clears the market globally for our clients process initiation, supported by our proprietary Best-in-class transaction execution insight into private market M&A valuations in Asia and worldwide Customized to industry and asset Selected BDA exits Premium advice and execution Divested Amazon Divested majority Divested Hyosung Divested 100% stake Agreed to be acquired Divested 100% stake Papyrus to stake in STS Group to Capital to to by to The Longreach group Adler Pelzer Group ST Leaders Private BWT Mindray CareCapital 60% Strategic buyers Equity 2021 2021 2020 2021 2021 2020 40% 60% 40% Financial sponsors Divested Compart Divested Escientia Life Divested a 100% stake Divested Thinh Phat Divested Asian Divested a 70% stake Systems to Sciences to in Young Toys to Cables and Dong Viet electronic cleaning to to chemicals business to Deccan Fine Shanghai Wanye MiraeN Group Stark Corporation Nippon Kayaku Affirma Capital Chemicals 2020 2020 2020 2020 2020 2019 6 Intelligent acquisition support Dedication to buyside M&A We assist our clients to identify and conclude cross-border transactions efficiently and on optimal terms Target qualification Acquisition execution Persistent and persuasive in our pursuit of potential sellers for our clients Highly experienced in assessing, structuring and negotiating transactions Identifying targets based Engaging with targets Thorough due diligence Valuation and pro-forma Price and SPA Positioning our client on clients’ criteria and building deal interest and process management synergy analysis negotiation BDA buyside engagements Acquired roller coaster Agreed to acquire 75% of Acquired Chinese food Acquired Acquired manufacturer, Vekoma Rides Acquired ingredients company Rich Graviss Tianning Flavours 2020 2020 2018 2017 2017 2016 7 Credibility with financial sponsors A valuable resource for financial sponsors Dedicated coverage team generating proprietary deal flow and exits Financial sponsor portfolio company exits The majority of BDA deals have financial sponsor involvement Divested 20% stake to Divested Amazon Divested majority Divested 100% stake Divested 100% stake Divested CSS Corp Papyrus to stake in STS Group to to to Kyushu Electric The Longreach group Adler Pelzer Group EagleTree Capital Escalent 2021 2021 2021 2021 2021 2021 Divested 100% stake Divested Compart Divested Escientia Life Divested a 100% stake Divested Epolin Divested significant to Systems to Sciences to in Young Toys to Chemicals to stake in Kehua Bio- Engineering to 60% Deccan Fine CareCapital Shanghai Wanye MiraeN Group Chroma Color Chemicals Gree Real Estate 2020 2020 2020 2020 2020 2020 High-volume, high-quality deal flow Deals since 2016 with financial sponsors as client and/or buyer/investor Divested majority Divested Hyosung Acquired by Acquired EMC Series B capital raise Strategic partnership stake to Capital to Holdings from in China and Broadreach and investment by DCP Capital ST Leaders Private Cedar Capital Affirma Capital EverYi Capital Equity Partners 2021 2020 2020 2020 2020 2020 Divested a 70% stake Divested majority Divested Nagano Raised growth capital Raised growth capital Majority recapitalized to stake to Industried to from by Affirma/SCPE The Longreach Group JAFCO Crescent Point Galen Partners 2019 2019 2018 2018 2017 2017 8 Credibility with financial sponsors The annual BDA Private Equity Conference Dynamic event where an exclusive group of private equity investors meet outstanding private companies Annual convene where blue-chip private equity investors meet outstanding private companies Unique platform for outstanding private companies in the chemicals,
Recommended publications
  • 2Nd FCF Life Science IPO Report

    2Nd FCF Life Science IPO Report

    FCF Life Science Research 2nd Life Science IPO Report – Initial Public Offerings in Europe and the US Enterovirus Part of FCF Life Science Research Series FCF Overview European and US Life Science IPOs C r o s s - border IPOs of European Issuers in the US Life Science IPO Outlook Appendix: European Cross - border Issuances in the US 2 FCF Overview FCF seeks to provide Who We Are Capital Markets Capabilities and Services its clients with ▪ Specialized investment bank and financing specialist financing Private / Venture capital financing Private equity financing ▪ Advising public and private small / midcap companies Pre-IPO Growth capital financing (i) at the lowest cost, ▪ Advisor for structuring and placement of financing transactions: Initial Public Offering (IPO) pursued in tandem) – All instruments: Unbiased approach to all available corporate Equity / Capital increase Private Investment in (ii) with the highest Public Dual-track (IPO and Public Equity (PIPE) flexibility, financing instruments (no product selling approach), allowing alternative transaction Block trade for customized financing structures (iii) in the shortest Receivables financing / Working capital / Revolving – All investors: Close and trusted relationships with senior period of time, Short-term Factoring / ABS credit facility executives of virtually all relevant equity and debt investors Debt Borrowing base / Guarantees / (iv) with the highest – Fast process: Process management skills and direct / personal Inventory financing Letter of Credit closing proba- access to institutional debt and equity investors enable fast Bank loan facility / Promissory note bility, and with transactions Straight debt (Schuldscheindarlehen) Debt Long-term Sale-and-lease back High-yield / PIK bond (v) financing partners ▪ More than 100 transactions with a total placement volume in Debt Corporate bonds (public / (public / private) that integrate well excess of EUR 4.0 billion since foundation in 2005 private placement) Second lien financing into their strategy ▪ Approx.
  • DENVER CAPITAL MATRIX Funding Sources for Entrepreneurs and Small Business

    DENVER CAPITAL MATRIX Funding Sources for Entrepreneurs and Small Business

    DENVER CAPITAL MATRIX Funding sources for entrepreneurs and small business. Introduction The Denver Office of Economic Development is pleased to release this fifth annual edition of the Denver Capital Matrix. This publication is designed as a tool to assist business owners and entrepreneurs with discovering the myriad of capital sources in and around the Mile High City. As a strategic initiative of the Denver Office of Economic Development’s JumpStart strategic plan, the Denver Capital Matrix provides a comprehensive directory of financing Definitions sources, from traditional bank lending, to venture capital firms, private Venture Capital – Venture capital is capital provided by investors to small businesses and start-up firms that demonstrate possible high- equity firms, angel investors, mezzanine sources and more. growth opportunities. Venture capital investments have a potential for considerable loss or profit and are generally designated for new and Small businesses provide the greatest opportunity for job creation speculative enterprises that seek to generate a return through a potential today. Yet, a lack of needed financing often prevents businesses from initial public offering or sale of the company. implementing expansion plans and adding payroll. Through this updated resource, we’re striving to help connect businesses to start-up Angel Investor – An angel investor is a high net worth individual active in and expansion capital so that they can thrive in Denver. venture financing, typically participating at an early stage of growth. Private Equity – Private equity is an individual or consortium of investors and funds that make investments directly into private companies or initiate buyouts of public companies. Private equity is ownership in private companies that is not listed or traded on public exchanges.
  • Focused. Diversified. Competent. Trustworthy

    Focused. Diversified. Competent. Trustworthy

    FOCUSED. DIVERSIFIED. COMPETENT. TRUSTWORTHY. GROUP ANNUAL REPORT 2016 DVB in Key figures at a glance € mn 2016 2015 % Earnings data Net interest income 209.0 183.7 13.8 ABOUT US Allowance for credit losses –381.4 –141.5 – THE SPECIALIST Net interest income after allowance for credit losses –172.4 42.2 – Net fee and commission income 119.2 103.3 15.4 IN INTERNATIONAL Results from investments in companies accounted for using the equity method 9.6 3.9 – Net other operating income/expenses 99.6 14.7 – TRANSPORT FINANCE Total income 56.0 164.1 –69.9 General administrative expenses –177.5 –180.9 –1.9 Net result from financial instruments in accordance with IAS 39 –2.7 70.8 – Consolidated net income/loss before bank levy, BVR1 Deposit Guarantee Scheme and taxes –124.2 54.0 – Consolidated net income/loss before taxes –135.3 46.1 – Consolidated net income/loss –138.7 45.6 – Key financial indicators Return on equity (before taxes, %) –10.8 0.8 – Cost/income ratio (%) 44.3 55.3 –10.0 pp Economic Value Added (€ million) –249.0 –86.8 – FOCUSED. GROUP MANAGEMENT REPORT Key items from the statement of financial position Business volume 29,187.0 28,207.6 3.5 Customer lending volume 25,876.4 25,272.5 2.4 Total assets 27,713.3 26,610.5 4.1 Loans and advances to customers 23,686.7 22,975.5 3.1 Deposits from customers 7,839.6 7,510.8 4.4 DIVERSIFIED. Securitised liabilities 12,722.3 13,141.9 –3.2 Subordinated liabilities 951.2 742.7 28.1 Equity 1,275.7 1,429.5 –10.8 Total capital in accordance with the Capital Requirements Regulation Common equity tier 1 1,012.0 1,147.3 –11.8 Tier 2 capital 584.0 432.0 35.2 COMPETENT.
  • News Release for Immediate Release August 11, 2015 The

    News Release for Immediate Release August 11, 2015 The

    News Release For Immediate Release August 11, 2015 The Carlyle Group to Purchase Veritas from Symantec for $8 Billion Will Invest Significantly in Emerging and Next Generation Technology Bill Coleman to Join as CEO, Bill Krause as Chairman Washington, DC – Global alternative asset manager The Carlyle Group (NASDAQ: CG) today announced that it has agreed to acquire Veritas, an information management systems provider, from Symantec Corp. (NASDAQ: SYMC) for $8 billion in cash. Seasoned technology executives Bill Coleman and Bill Krause will become CEO and Chairman, respectively. Equity for the transaction will come from Carlyle Partners VI, together with GIC, Singapore’s sovereign wealth fund, and other coinvestors. The transaction, subject to regulatory approvals and other conditions, is expected to close around year end. Patrick McCarter, a Managing Director based in Carlyle’s Silicon Valley office, said, “Veritas is a market innovator with global scale, an iconic brand, and significant growth potential. Bill Coleman is a proven leader whose strategic vision and strong execution skills will leverage Veritas’s new-found position as a private, stand-alone company to grow the firm and provide customers an integrated information management solution.” Carlyle Managing Director Cam Dyer added, “Our significant experience investing in software businesses, as well as our extensive experience with carve-out transactions, positions us well to support Bill and the existing management team in creating value at Veritas.” Founded in 1983 and headquartered in Mountain View, CA, Veritas is a provider of storage and server management software solutions, with #1 or #2 market positions in the majority of its current product offerings, which enable customers to protect and manage critical IT infrastructure and applications.
  • Proxy Statement

    Proxy Statement

    September 8, 2021 To our shareholders: I am pleased to invite you to the 2021 Annual General Meeting of Shareholders (the "Annual General Meeting") of Quotient Limited (“Quotient”, the “Company” or "we", "us" and "our") to be held on October 29, 2021, at 9:00 a.m., local time, at Business Park Terre Bonne B1, Route de Crassier 13, 1262 Eysins, Switzerland. Information about the meeting is presented on the following pages. Details regarding admission to the meeting and the business that will be conducted are described in the accompanying Notice of Annual General Meeting (the "AGM Notice") and Proxy Statement. In accordance with the “notice and access” rules and regulations adopted by the Securities and Exchange Commission (the "SEC"), instead of mailing a printed, paper copy of our proxy materials to each shareholder who holds shares in street name (the “full set delivery” option), we are furnishing proxy materials to those shareholders over the Internet (the “notice only” option). A company may use either option, “notice only” or “full set delivery,” for all of its shareholders or may use one method for some shareholders and the other method for others. We believe the “notice only” process expedites shareholders’ receipt of proxy materials and reduces the costs and environmental impact of our Annual General Meeting. We will bear the entire cost of the solicitation. On or about September 8, 2021, we will begin mailing a notice (the "Notice of Availability") to our shareholders containing instructions on how to access online our Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended March 31, 2021, filed with the SEC on June 3, 2021 (our "Annual Report"), vote online, and receive paper copies of these documents for shareholders who so select, as well as a link containing instructions on how to vote by telephone.
  • Dealogic Leverages Logitech Group, Meetup, and Smartdock to Enhance Global Collaboration and Training

    Dealogic Leverages Logitech Group, Meetup, and Smartdock to Enhance Global Collaboration and Training

    CASE STUDY DEALOGIC LEVERAGES LOGITECH GROUP, MEETUP, AND SMARTDOCK TO ENHANCE GLOBAL COLLABORATION AND TRAINING. Dealogic, a global provider of integrated content, analytics, and technology to financial firms, uses Logitech GROUP, MeetUp, and SmartDock to enhance worldwide collaboration and training. CHALLENGE When Dealogic decided to incorporate the global reach, flexibility and cost-saving potential of video meetings into their infrastructure, they wanted a high-performance, cost-efficient, and user-friendly INDUSTRY solution with minimal support requirements and seamless Technology (Computer Software) compatibility with their UC platform. LOCATION Hong Kong, Tokyo, Beijing, SOLUTION Singapore, Mumbai, Sydney, Dealogic selected MeetUp (Logitech’s all-in-one video conference Budapest, Sao Paulo as well solution for huddle rooms and small conference rooms), GROUP as London and New York (the amazingly affordable ConferenceCam for larger-sized WEBSITE conference rooms), and Logitech SmartDock (a secure meeting dealogic.com room console designed for Skype® room systems). RESULT PRODUCTS USED The combination of Logitech GROUP, MeetUp, and SmartDock is making it possible for Dealogic to enhance global collaboration and training while fulfilling its objectives for affordability, performance, and ease of use. Plus, it was a breeze for Dealogic to set up and install. Logitech MeetUp “As a global enterprise, we need to get close and communicate with different teams in other regions. When evaluating video collaboration options to support this objective, we prioritized budget, performance, and ease of use as key criteria. Logitech surpassed our expectations on all counts.” Logitech GROUP JASON LEE APAC Desktop Team Leader Dealogic Logitech SmartDock.
  • Building Michigan's Vibrant Future

    Building Michigan's Vibrant Future

    BUILDING2 MICHIGAN’S0 VIBRANT1 FUTURE1 “THESE GUYS CAN ADD A ZERO.” “WE’VE GROWN 43% OVER THE LAST TWO “WHEN I SAW THE RESULTS FROM THE AD CAMPAIGN, Josh Linkner, CEO and Managing Partner, YEARS. THEIR MADNESS WORKS.” I THOUGHT SOMEONE SCREWED UP PLACING A Detroit Venture Partners Tim Marshall, President, Bank of Ann Arbor DECIMAL POINT.” John Lichtenberg, CMO, Walsh College BRANDING THAT HITS. Perich Ad_VCA.indd 1 4/9/12 11:44 AM TABLE OF CONTENTS Executive Summary ...................................................................................3 Michigan Venture Capital Association................................................4 National and Midwest Venture Capital ..............................................6 Michigan Venture Capital Summary ................................................. 12 Michigan’s Successful Exits .................................................................. 30 Angel and Pre-Seed Summary ............................................................. 34 MVCA Activities .........................................................................................40 Michigan Venture Capital and Angel Network Directory ............................................................. 42 Photography by Leisa Thompson and Jeff Borisen. Helping entrepreneurs build great companies in the software, digital media, education technology and health information technology markets Michigan Office: 130 S. First Street, Suite 201 $250 MILLION IN CAPITAL Ann Arbor, MI 48104 UNDER MANAGEMENT PH: (734) 663-6500 www.mkcapital.com
  • Healthcare & Life Sciences

    Healthcare & Life Sciences

    HEALTHCARE & LIFE SCIENCES Industry Update │ May 2021 Healthcare & Life Sciences INDUSTRY UPDATE │ May 2021 Healthcare & Life Sciences Industry Overview QUICK TAKE: HEALTHCARE AUTOMATION Operating on tight margins and with lives at stake, healthcare providers are embracing automation as a way to ensure process quality while optimizing efficiency. Here, senior members of the Harris Williams Healthcare & Life Sciences Group share insights on the top considerations for investors exploring opportunities in the healthcare automation solutions sector, with a special focus on pharmacy automation. Read the article. M&A ENVIRONMENT ( 1 ) There have been roughly 625 M&A transactions in the healthcare and life sciences industry since the beginning of 2021, worth roughly $100 billion, compared with approximately $222 billion for all of 2020. Notable recent transactions include the acquisition of PPD Inc. (NasdaqGS: PPD) by Thermo Fisher Scientific Inc. (NYSE: TMO), Kindred Healthcare LLC by Humana Inc. (NYSE: HUM), and Luminex Corporation (NasdaqGS: LMNX) by DiaSorin SpA (BIT: DIA). PUBLIC COMPANY PERFORMANCE ( 1 ) Stock prices increased for many healthcare and life sciences companies during the past three months. In fact, the Harris Williams HCLS Composite Index increased 10.1%, while the S&P increased 12.6%. Notable sector increases include assisted living (increased 48.3%), healthcare staffing (increased 31.0%), and dental products (increased 21.8%). Industrywide stock prices have experienced increases as a whole; the HCLS Composite Index showed an increase over the past 12 months of 67.3%. At the category level, provider-based services grew by 67.7% on average over the past 12 months, followed by payor, provider, and pharmacy support services increasing 37.6% and products and devices stock prices increasing 35.4%.
  • Monthly Healthcare Review July 2017

    Monthly Healthcare Review July 2017

    Monthly Healthcare Review July 2017 IPOs The following table includes the medical devices, biotechnology, pharmaceuticals, and healthcare IPO pricings, filings and withdrawals announced over the previous month. Last Last Financing Financing Company Name HQ Location Description Lead Manager Date Size (Millions) Promore Pharma Owner and operator of a bio-pharmaceutical company developing therapeutic peptides for (PROMO) 6-Jul-17 Solna, Sweden treating local wounds and infections. 8.74 Undisclosed Network 1 Financial Operator of a molecular diagnostics company offering a DNA-based testing platform that Securities, Network Co-Diagnostics specializes in the development of probes for real-time PCR to its customers. It also 1 Securities, (CODX) 12-Jul-17 Sandy, UT develops a design and analytics software for DNA test designing. 7.07 WallachBeth Capital The company is engaged in the extraction and purification of heparin glycosaminoglycan NKF Pharmaceuticals and develops a controlled, traceable, and detectable process for the production of crude (603707) 13-Jul-17 Nanjing, China heparin. 67.22 Undisclosed NextCell Pharma Huddinge, (NEXTCL) 13-Jul-17 Sweden Provider of medical products for autoimmune and inflammatory diseases and transplants. 2.88 Undisclosed Akcea Therapeutics Developer of RNA-targeted antisense therapeutic products created to transform the lives of BMO Capital (AKCA) 14-Jul-17 Cambridge, MA patients with serious cardiometabolic lipid disorders. 175.00 Markets Provider of nutritional supplements and medical devices for the restoration of the ability to PharmaNutra (PHN) 18-Jul-17 Pisa, Italy articulate and movement in osteoarticular affections. Undisclosed Undisclosed Developer of innovative nanoparticle-based treatments created to treat ocular diseases BofA Merrill Lynch, Kala Pharmaceuticals affecting both front and back of the eye, such as dry eye disease and post-surgical ocular J.P Morgan (KALA) 20-Jul-17 Waltham, MA inflammation and pain.
  • Silicon Valley London Woodside Capital Partners (WCP)

    Silicon Valley London Woodside Capital Partners (WCP)

    Silicon Valley London Woodside Capital Partners (WCP) proudly releases the inaugural healthcare report “State of Digital Health”. In 2016, healthcare cost in the US was $3.3 Trillion – 17.9% of GDP, passing $10,000 per capita mark for the first time ever. According to CMS, by 2026, the figure is projected to grow to $5.7 Trillion – 19.8% of GDP. The answer to curbing and reversing the trend with respect to healthcare costs lies in large part to the movement towards Digital Health, or ‘Health Tech’. The proliferation of devices and applications across the healthcare spectrum has led to a data tsunami – the “what”. Machine Learning, Artificial Intelligence and overall Big Data analytics are leading to real-time actionable insights – the “so what”. We have entered the realm of the Internet of Medical Things (IoMT), with ubiquitous connectivity and measurement of everything from our vitals and nutrition to physical activity and medical compliance. We are just starting to leverage that data in a meaningful way and seeing early impact on health and well-being. In 2017, venture investments in Digital Health startups exceeded $6 Billion for the first time, and the trend seems to be accelerating with $1.6 Billion invested in Q1, 2018. The juxtaposition of rising healthcare costs and increased Digital Health investments is not all that surprising. Advances in underlying real-time analytics and potential of leading edge innovations around genomics are turning the perceived fiction of personalized medicine into a real possibility. Foundational disruptions such as Blockchain, while relatively nascent, are creating excitement (and some anxiety) around secure, immutable data sharing across silos – with healthcare as the ideal use case.
  • Deal Drivers: Americas Q1 2021

    Deal Drivers: Americas Q1 2021

    Deal Drivers: Americas Q1 2021 A spotlight on mergers and acquisitions trends in 2021 Contents Foreword 03 Outlook 04 Summary 05 Canada 08 Western US 12 Midwestern US 16 Southern US 20 Northeastern US 24 Brazil 28 Latin America & the Caribbean (excl. Brazil) 32 About this report 36 2 Foreword: North-South divide underpinning uneven recovery After a challenging year that saw deal activity freeze through The US has led the way, with deal value more than H1 2020 as the outbreak of COVID-19 forced countries into doubling year-on-year in Q1 2021 to reach US$658.73bn. lockdowns, the M&A market in the Americas has reset and The conclusion of the US presidential election and the recovered, posting steady deal numbers through Q1 2021. inauguration of Joe Biden have given capital markets Aggregate deal value for the region reached US$658.73bn more certainty. The country has also benefited from a mass from 1,961 transactions announced in Q1 2021, up from roll-out of COVID-19 vaccines, with almost 100m people in US$236.77bn from 1,918 deals in the same period last year. the US fully vaccinated through the early months of this year. Outside of North America, deal markets in Brazil and But while the headline gains in M&A elsewhere in Latin America have also seen improvement activity offer reasons for optimism in in Q1 2021, but the rebound hasn’t been as pronounced. the deal community, the recovery has The outlook for the rest of the year is also less certain, with been noticeably uneven.
  • Advertising.Pdf

    Advertising.Pdf

    YOUR AWARDWINNING SUPPLEMENT business-reporter.co.uk LEADERS OF DISTRIBUTED WITHIN THE SUNDAY TELEGRAPH, PRODUCED AND PUBLISHED BY LYONSDOWN WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS THEYOUR AWARDWINNING SUPPLEMENT PACK! Golden glow for the Dragons’ Den duo Global ambitions of British entrepreneurs who have set their sights on the tanning market | Page 5 June 2014 WOMEN IN BUSINESS Business Reporter prize at prestigious scoops industry top awards | Full story page 6 March 2014 What | business-reporter.co.uk Exclusive interview with shadow business emerging markets happened secretary Chuka Umunna The power behind decisions JULY Internet ofKeeping things next? "The sink doesn’t have a clue what it’s talking about.British I agree withbusiness the fridge" competitive Exclusive interview with Dr Leah Totton, e A p p r e n t i c e winner 2013 | Pages 8 and 9 in a global economy ents Pages 8-9 own which takes sole responsibility for the cont D yons l by publisheD D Dave Baxter reports from Brazil ahead of this year’s World Cup on a an uceD country that is finding its place on the international stage | Pages 4-5 D elegraph, pro t ay D un INSIDE s The schoolboy whose idea was sold to Yahoo! for $30m within the D DISTRIBUTED WITHIN THE SUNDAY TELEGRAPH, PRODUCED AND PUBLISHED BY LYONSDOWNExclusive WHICH TAKES SOLE RESPONSIBILITYinterview FOR THE CONTENTSwith Nick D’Aloisio | Pages 8-9 We have been setting the pace for months now withDistribute brilliant interviews, excellent analysis and engaging features in our award-winning supplements. Here’s a small reminder of what we’ve been up to..